No quarterly revenue total was found in VERDE BIO HOLDINGS, INC.'s SEC filings.
Verde Bio Holdings, Inc. (APHD) files with the SEC under industry code 1311, Crude Petroleum & Natural Gas.
Revenue
—
Net income
$-1.49M
-239.5% vs year-ago quarter
Operating cash flow
$-314,334
-2.5% vs year-ago quarter
Free cash flow
$-240,290
-1544.5% vs year-ago quarter
EPS
$0.00
Dividend per share
None
Shares outstanding
2.02B
+37.5% vs year-ago quarter
Net cash
$39,975
Q2 FY2024
Operating margin
—
Company profile
- Industry
- Crude Petroleum & Natural Gas (SIC 1311)
- Listed as
- APHD (OTC)
- Fiscal year ends
- April 30
- Incorporated in
- NV
- Headquarters
- Frisco, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1490054
- Former names
- APPIPHANY TECHNOLOGIES HOLDINGS CORP (until Aug 20, 2020)
Other Crude Petroleum & Natural Gas companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2024 Jan 31, 2024 |
Q2 FY2024 Oct 31, 2023 |
Q1 FY2024 Jul 31, 2023 |
Q4 FY2023 Apr 30, 2023 |
Q3 FY2023 Jan 31, 2023 |
|---|---|---|---|---|---|
| Operating income | -$410,490 | -$303,328 | -$326,953 | -$402,013 | -$414,177 |
| Net income | -$1.5M | -$350,826 | -$336,648 | -$529,408 | -$439,836 |
| Diluted EPS | $0.00 | — | — | — | — |
| Operating cash flow | -$314,334 | -$240,290 | -$388,585 | -$155,208 | -$306,542 |
| Free cash flow | — | -$240,290 | -$388,585 | -$155,208 | -$306,542 |
| Total assets | $1.9M | $3.7M | $3.9M | $4.2M | $4.3M |
| Total liabilities | $1.6M | $2.0M | $1.9M | $1.8M | $1.6M |
| Stockholders' equity | $119,018 | $1.5M | $1.9M | $2.2M | $2.7M |
| Cash and investments | $11,561 | $39,975 | $200,265 | $25,836 | $50,063 |
| Total debt | — | $0 | $5,454 | $21,337 | $36,627 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Acquisition or sale of assets, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
May 13, 2024 | May 9, 2024 |
| 8-K |
Current report
Acquisition or sale of assets
|
Mar 26, 2024 | Mar 20, 2024 |
| 10-Q | Quarterly report | Mar 25, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Auditor change
|
Mar 1, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 13, 2024 | Feb 12, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 20, 2023 | Dec 19, 2023 |
All 309 Verde Bio Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.